Treatments for acne, psoriasis and rosacea
Raised to date
$6.7M
of $6.7M offered across 3 Form D filings
Dermata Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the development of innovative treatments for a range of skin diseases and aesthetic conditions. By leveraging both mechanical and chemical mechanisms, Dermata aims to deliver more effective solutions for dermatologic issues, including acne, psoriasis, and rosacea.
Dermata stands out due to its novel approach that simultaneously utilizes mechanical and chemical mechanisms to address various dermatological conditions, enhancing treatment efficacy.
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Jan 7, 2026 | Equity | $4.1M/ $4.1M | Form D |
| Feb 4, 2025 | Equity | $2.5M/ $2.5M | Form D/A |
| Jan 28, 2025 | Equity | $2.5M/ $2.5M | Form D |
Dermatology treatments
Dermata Therapeutics is developing a range of dermatology products derived from natural technologies, targeting dermatologic conditions through a combination of mechanical and chemical actions.
Built for
Patients with dermatologic conditions
